chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had no immediate reactions to the vaccine. About an hour after my injection I developed a low grade headache. The next day, 2/26, I woke at 7am with a headache still. The headache and fatigue worsened through the day (2/26/21).  Around 3:00pm I started experiencing waves of dizziness. By 4pm I had begun experiencing temporary loss of feeling in  various body parts. Each part's loss of feeling came and went separately and lasted about 2-5 minutes each. I experienced this in my left facial cheek, both wrists and hands, and my right hip. I had a coworker drive me home and by 5pm I had a migraine with severe sinus/head pressure and a fever of 99.4. My average resting body temperature is 97.4. I slept from 6:00pm friday till 10:30am on Saturday (2/27). When I woke I still had a headache, but no longer a migraine.  I spent 2/27 dizzy, weak, and achy but no more episodes of lack of feeling in body parts or a fever.  I have not experienced soreness in the arm I got my injection in, but I noticed on Tuesday March 2nd that I my injection site is very swollen, red and itchy. The swelling and redness (to my knowledge) has not gotten worse or better since then, but the itching has gotten worse and the actual puncture wound is now visible since yesterday (3/4) whereas it was not visible anytime  before  that.
This spontaneous report as received from a health care worker refers to currently 4 year old child patient of unknown gender. No information about medical history, concurrent conditions was reported for the patient. On 22-APR-2015 the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (dose in series unspecified) lot # K005427, expiration date 15-APR-2016, 0.5 ml, once subcutaneously for routine vaccination. No adverse effects reported. The outcome of events reported was unknown. No product quality complaint was involved. This case is linked to the case 1506USA007806 via same reporter link. Additional information has been requested.
pt recvd flu vax & exp pain in the arm of inject from neck to the hand; pt continues to have pain 1 mo p/vax;
Father noted a red raised rash on patients upper Left Arm. Area was slightly warm to the touch. Didn't bother patient at all. Tylenol given for fever. By 8/5/11 rash was gone.
1 hr p/vax devel itching, hives, swollen eyes, swollen lips, some cough; no hypotension, wheezing, or stridor; given Epi, Solumedrol; rx for Decadron, DPH;
Alerted by vaccination RN at 12:01 PM that the first 8 doses administered of the day had been given in insufficient amount. The RN stated she realized with the last patient of the morning (receiving dose #9) that the syringe was not the 3mL syringe she was used to using, and was in fact a 1mL insulin syringe. She noted that she had been drawing up the vaccine up to 5 (meaning 5 unit, equivalent to 0.05mL) rather than to 50u to give the full dose (0.5mL).  She stated she recognized her error with patient #9 and administered the correct amount (0.5mL) from a 3mL syringe she was used to using.  In addition to contacting COVID-19 provider, the patient was contacted and left a VM for the patient to call back so the incident could be explained and an opportunity to reschedule to give full dose could be offered.  At the end of the day, when counting dose administered and factoring in the estimated amount of vaccine wasted due to insufficient dosages, there was just under 9 doses accounted for. The vaccinating RN was questioned again to see if there was any possibility any of the initial 8 patients received a full dose of the vaccine without her realizing it. She stated she did not believe she ever drew up the 1mL syringe to 50u nor administered a 0.5mL dose using the 3mL syringe, though she stated she couldn't say for sure. She said the container holding the syringes had each type divided in one compartment and separated from each other. The COVID-19 provider was informed of this information and additional guidance was requested.
After receiving Flu vaccine: throat swelling; hoarsness; headache; right side of face tingling; body aches; shortness of breath (could hardly walk from chair to bathroom); decreased peak flows; temp of 102.7; lack of energy to function normally  contacted Dr  -No repsonse returned.   headache; occasional fever; body aches still continue; still decreased energy.  Treatment was provental inhaler; benadryl; tylenol;
nauseous; threw up several times; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseous) and VOMITING (threw up several times) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     Concomitant products included HYDROCODONE for Pain, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] for an unknown indication.    On 22-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced NAUSEA (nauseous) and VOMITING (threw up several times). The patient was treated with BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) for Adverse event, at a dose of UNK dosage form. At the time of the report, NAUSEA (nauseous) and VOMITING (threw up several times) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Delayed response 1-week after injection (4/28/2021) - itchy, red, swelling at the site of the injection, redness and swelling went from site of injection (deltoid) down to elbow. Swelling and redness lasted 10-days (and then decreased to occasional redness and little swelling until day 14.
DESPITE repeatedly questioning the risks of administering so many vaccinations at once, including live Rotavirus, we were repeatedly assured that this was customary so that our 7 month old son could "catch up" with on inoculation schedule as the vaccines had not been available for months. Within two day of receiving his shots, patient stopped eating solid foods. Over the next couple of days our son began having episodes of inconsolable crying; refused to drink his breast milk and developed a persistent fever. We took him back at our pediatrician's office on the 7th July and were assured by Dr that patient simply had a sore throat or was teething! When our son's fever rose to 104.9F (41.6C) he started projectile vomiting and little red lines appeared on his hands and feet (which she informed us it wasn't Meningitis but we know to be petechiae) we took back to his pediatrics office who said he has a virus and instructed us to rotate giving him COPOL and Ibuprofen and go the hospital for a blood test. The next day the doctor called and said he bloods were not that bad. Saturday night he started having severe diarrhea and his temperature soared to 107.1F. We placed him in an ice bath and head straight to the Emergency Room. The ER team informed us that his platelets had crashed; he was neutropenia and needed an immediate blood transfusion in order to survive. As our son's condition deteriorated rapidly, over the next 3 days and patient was placed into Pediatric ICU. As doctors were stumped we decided to air- ambulance him to another Hospital. Within 4 hours, Dr diagnosed with an often fatal, blood autoimmune disease HH; and, he began an aggressive treatment protocol for his condition.
Case number PHEH2015US024595, is an initial spontaneous report from a pharmacist (also patient) received on 20 Nov 2015. This report refers to a 33 years old female patient. Medical history and concomitant medications were not reported. On 06 Nov 2015 when the pharmacist was withdrawing the first dose from MDV of FLUVIRIN (batch number: 1514801) the vial leaked on to her skin. The vial leaked from area of metal collar. After exposure the pharmacist washed her hands and had no redness or other symptoms. No additional information was available.
NEUROPATHY; SHOULDER WAS NOT NORMAL; This spontaneous report received from a patient via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient was a power lifter before the vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on an unspecified date in AUG-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced neuropathy. Patient stated that as per neurologist, neuropathy was not listed under the side effects of vaccination. Patient reported that no one was knowing that if her shoulder would get back to normal or not.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shoulder was not normal, and the outcome of neuropathy was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000199077.; Sender's Comments: V0:20211048891-covid-19 vaccine ad26.cov2.s-Neuropathy- This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Client was in the monitoring room after receiving first dose.  Reported to the nurse  felt like throat was swelling and  having difficulty breathing and swallowing.  Nurse reported client was visibly having a hard time with breathing.   Client reported felt weak and legs felt "like noodles."  Epi Pen given Left thigh.  911 called .  Client accepted transport for further evaluation.
uneasiness; dizziness; difficulty breathing; numb hands; cold sweats; shaking; chest pain; hands turned blue; vision was blurry; This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands) and HYPERHIDROSIS (cold sweats) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 08B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and BIOTIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
pt arm sore, woke up 2 times @ noc;couldn't move arm, tender @ shot site;extreme pain, hand turning blue, could not raise arm;saw MD poss adverse rxn-needle hit a nerve;
Starting on 3/14/2012 child developed rash affecting entire body. Child states rash did itch and parents noted he was scratching. Rash is red, raised bumps, no pustules noted.
Swelling; Pain; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site swelling and injection site pain. On an unknown date, the outcome of the injection site swelling and injection site pain were recovered/resolved.   It was unknown if the reporter considered the injection site swelling and injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced severe reaction of pain and swelling at the injection site following first dose at an undisclosed date or time frame. The reporter declined to provide further demographic information. There was a discrepancy with respect to the primary reporter type, whether the primary reporter was a pharmacist or a consumer, the clarification was raised to confirm the type, however no clear information available for the same hence the clarification has been raised to seek more information regarding that the primary reporter type.
About 15 min after the vaccines, client passed out as reported by his friend. He was sitting on the floor when I came to him, very pale. Stated his stomach hurt, then had small emesis. Cold pack applied to forehead, moved him to supine position with knees elevated. Stayed with client for about an hour until school resumed. He as feeling better by then, drinking apple juice
Patient had vaccine 7/27/18 and had KEYTRUDA chemo administered on 8/13/18; Pt developed rash on lower back on 8/16/18; Pt went to see FNP 8/20/18 and reported the rash; Per pt rash was a different location and different symptoms as the usual rash that develops after KEYTRUDA; FNP examined pt and DX was shingles; rash described as blistering per pictures taken by FNP, itchy/painful as described by pt; Pt given valacyclovir RX and picked up 8/21/18 by pt.
Dizziness; I woke up dizzy this morning; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EM9810), via an unspecified route of administration on an unspecified date, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness which patient never really had before.Patient wants to know if it can affect  4 days later. Patient woke up dizzy this morning and that's it. The shot had an effect four days later. The outcome of the event was unknown.
8 Days after the vaccine I had redness, heat and pain where the vaccine occured. I also had and still have an enlarge lymphnode under my arm pit where the vaccine was administered. I was also fatigued and felt wiped out.
55 y/o male with hx of anaphylaxis due to peanut allergy.  Guardian pharmacist noted the change in facial color and alerted RN who was monitoring s/p vaccination of her observations.  He was red with facial edema upon my arrival.  Benadryl 25mg PO while he was still able to swallow by RN.   EMS called while he took the Benadryl.  After Benadryl, checked vitals ? VERY hypertensive and increasing diaphoresis; Started to wax and wane with consciousness.  Administered epi pen by RN in attendance once change in level of consciousness was noted.  After epi, became pale, increasing diaphoresis with change in level of consciousness.  BP was lower, still hypertensive.  Placed on floor by staff.  While on the floor, consciousness improved.  EMS arrived and assumed care.
Patient fainted and fell after the vaccine was administered by my tech.  Pharmacist observed patient on the floor jerking/twitching like patient was having seizure. 911 was called. Patient came to consciousness in approx 45seconds.  Patient bit his tongue during the incident so had bleeding.  Pt admitted that he was very nervous, and did not eat any breakfast today.  Vitals: BP 105/54 HR 54bpm.  Pt was not having anaphylaxis reaction.  Pt was breathing fine.  Pt was having headache afterwards.  Pt declined to go to ER with ambulance, as patient stated he will follow up with his PCP.  Followed up with the patient on 12/08 and patient stated patient has migraine and bump on head where he fell but otherwise doing fine.
I did not have an adverse reaction to the vaccine. I became systematic on 06/12/22 and tested negative for COVID-19. I tested positive for COVID-19 06/13/2022.  I was prescribed Paxlovid which helped with my  symptoms of sore throat, runny nose and congestion.
pt recv vax 8OCT96 @ noon;awoke about 1AM w/small amt diarrhea & vomiting & again @ 6AM w/more severe vomiting w/diarrhea;that was last episode;able to retain fluids & toast c/o lethargy @ this time 12:20 noon;NOS;
dizziness; headache; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea). On 17-Mar-2021, the patient experienced DIZZINESS (dizziness). The patient was treated with MARIJUANA for Headache, at a dose of Marijuana candy bar. At the time of the report, DIZZINESS (dizziness), HEADACHE (headache), FATIGUE (fatigue) and NAUSEA (nausea) had resolved.            No Concomitant medication was received by the patient  The patient  took a marijuana candy bar to help with her headaches.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of the events was updated to resolved.
Per patient started itching everywhere and redness at site approx. Oct. 3rd and 4th. Sent to Allergist and received a Rx MEDROL dose pak.
Fever and heart rate over 130 (while lying down) during the first day. Second day, migraine headache and nausea. Third and fourth days, upset stomach and exhaustion. I could not eat in 2 days, just water and coconut water. I ate only vegetable puree for 3 days.
Information has been received from a physician concerning a male married patient who was vaccinated with a dose of varicella-zoster virus vaccine live (Merck). Subsequently the patient developed shingles. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/14/2006. Additional information has been received from a physician who reported that the patient's shingles was diagnosed by a dermatologist. Additional information has been requested.
Severe pain in muscles of arm where the shot was received, lasting 2+ weeks and continue to persist. Prescribed muscle relaxer
In 24 hours after immunization, patient experienced unusual muscle pain. He complained that he could not raise his arm, the pain radiated from shoulder to the elbow & lasted 10 days.
not feeling well/feeling unwell; aches all over his body/Aches all over with muscles pains; muscle pains; headache; joint pain; chills; Injection site pain on left arm; body slightly warm/felt slightly warm; This is a spontaneous report from a contactable consumer (Patient's wife). A 81 years old male patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine, lot number EL3247 or EL3427), via an unspecified route of administration at Arm Left on 21Jan2021 09:33 at the 81 years old at single dose for COVID-19 immunization.   The medical history was none. The family medical history was none. The concomitant medications included warfarin from Mar2012 for Atrial fibrillation( AFib) and standard medications . The patient was not feeling well. All occurred on 21Jan2021 18:00, the patient developed symptoms, such as aches all over his body, aches all over with muscles pains with muscle pains, headache, joint pain, chills, injection site pain on left arm, body slightly warm, felt slightly warm, feeling unwell. He had chills all night and could not get warm. The reporter had not taken the patient's temperature yet. The patient takes regular medications. The patient was on warfarin and standard medications. The reporter stated the vaccine cards were mixed up because they did not write their names on them and the vaccine lot numbers looks like they were mixed up. Someone probably made a mistake because one says EL3247 and the other says EL3427, so she is not sure which it is. The handwriting is different on the cards. There was no Additional Vaccines Administered on Same Date of the Pfizer Suspect. There was not Emergency Room Visit or physician's office required Prior Vaccinations (within 4 weeks). The outcome of the event was not recovered.
4 days post  vaccine I got Bells Palsy. Went to hospital for  diagnosis on 5th  day. Put on prednisone and valtrex.  Total paralysis on  left side of face. Currently under the care of a neurologist, opthalmologist, acupuncture, massage and general practiioner. I tested COVID positive on 1/7 and 1/21. Tested negative on 1/28. Received vaccine 25 days after negative test.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The patients' current conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored (9 °C to 25 °C for 1 hour) (incorrect product storage) GARDASIL 9 lot # M042853 expiration date:17-JUL-2019 (strength, dose and route of administration were not reported) for prophylaxis. No adverse effects were reported. No previous temperature excursion was reported.The outcome of incorrect product storage and no adverse effect was unknown. This is one of the several reports received from same reporter.; Sender's Comments: US-009507513-1707USA009369: US-009507513-1707USA009371: US-009507513-1707USA009370:
Patient received the COVID bivalent booster first in the left arm and then the flu shot in the left arm second. A second after he got the flu shot, he started having a seizure like activity that lasted for about 30 seconds. He lost consciousness and would not respond. After he came to, he didn't remember anything that just transpired. I called for an ambulance while he was in that state and canceled it after he regained consciousness because he did not wish to go to the hospital. There was no loss of bowel or bladder function and no foaming at the mouth. He denied having  similar episodes with vaccines previously or any seizure disorder. He did not appear to be a post ictal state and answered questions appropriately. His vital signs were normal and stable. He was monitored in the office for 30 additional minutes. And his vital signs were stable after that as well. He did have the monkeypox vaccine less than a month before this one even though he didn't recall that and said that it has been more than a month. But we checked the records and it stated that he got it on 09/02/2022. SO it has not been more than 4 weeks and he verbalized understanding of the risks of having gotten the booster dose now.